Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Operating-Expenses" stands at 83.74 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2013.
Shionogi & Co. Ltd.'s first quarter result of 27.48 Billion JPY for the item "Other Operating Expenses" represents an increase of 470.70 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 27.48 Billion JPY for the item "Other Operating Expenses" represents an increase of 7.33 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 83.74 Billion JPY for the item "Other Operating Expenses" represents an increase of 2.29 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 48.84 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 48.84 Billion Japanese Yens.
The 3 year change is 88.94 Billion Japanese Yens.
The 5 year change is 119.07 Billion Japanese Yens.
The 10 year change is 13.70 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |